Riskpilot← Back to searchSign inGet full accessAberg Medical Oy
OYDissolvedY-tunnus 2529622-3Melkonkatu 5-A12Dental practice care activities · NACE 8623Est. 2013— employees
Revenue 2025
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2025
EUR 5K
+12% vs 2024
| Revenue | — | — |
| EBITDA | — | — |
| Net profit | EUR 5K | +12% |
| Total assets | EUR 126K | -4% |
| Equity | — | — |
| Employees | — | — |
Legal name
Aberg Medical Oy
Y-tunnus number
2529622-3
Legal form
Osakeyhtiö
NACE code
8623 · Dental practice care activities
Founded
1. helmikuuta 2013
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimiala on hammaslääkäripalvelujen tuottaminen potilaille, alan koulutus- ja konsultointipalvelujen tuottaminen sekä kustannustoiminta. Yhtiö voi omistaa, hallita ja vuokrata kiinteistöjä, liike- ja asuinhuoneistoja sekä kulkuneuvoja. Yhtiö voi harjoittaa arvopaperikauppaa.
Address
Melkonkatu 5-A12
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 134 | 238 | — | — | — |
| Staff expenses | −69 | −170 | — | — | — |
| EBITDA | 28 | 20 | — | — | — |
| Depreciation & amort. | −1 | — | — | — | — |
| EBIT | 28 | 20 | 33 | 9 | 41 |
| Net financials | −1 | −0 | — | — | — |
| Profit before tax | 27 | 20 | 28 | 6 | 37 |
| Tax | 1 | 5 | 6 | 1 | −1 |
| Net profit | 26 | 15 | 22 | 5 | 5 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 43 | 149 | 72 | 131 | 126 |
| Equity | 25 | 38 | — | — | — |
| Long-term debt | — | — | — | — | — |
| Short-term debt | 18 | 111 | — | — | — |
| Total debt | 18 | 111 | — | — | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212025
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20212025
Return on equity
547500.0%
This company
18.4%
Market median
+2975443% vs market
20212025
Net profit margin
547500.0%
This company
8.1%
Market median
+6759159% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
125501.00×
This company
0.62×
Market median
-20241997% vs market
20212025
- Annual report 2025Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
RK Deputy Member | Deputy Member | 2013 |
TM Chief Executive Officer | Chief Executive Officer | 2013 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aberg Medical Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Riikka Kaarina Åberg | Deputy Member | 0 companies |
| Thomas Mikael Åberg | Chief Executive Officer | 0 companies |